标题
IL-6 in diabetes and cardiovascular complications
作者
关键词
-
出版物
BRITISH JOURNAL OF PHARMACOLOGY
Volume 171, Issue 15, Pages 3595-3603
出版商
Wiley
发表日期
2014-04-04
DOI
10.1111/bph.12713
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pro-atherogenic lipid changes and decreased hepatic LDL receptor expression by tocilizumab in rheumatoid arthritis
- (2013) Aart C. Strang et al. ATHEROSCLEROSIS
- Impact of inflammatory biomarkers on relation of high density lipoprotein-cholesterol with incident coronary heart disease: Cardiovascular Health Study
- (2013) David M. Tehrani et al. ATHEROSCLEROSIS
- The Concise Guide to PHARMACOLOGY 2013/14: Catalytic Receptors
- (2013) Stephen P.H. Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- Circulating Inflammatory Markers and the Risk of Vascular Complications and Mortality in People With Type 2 Diabetes and Cardiovascular Disease or Risk Factors: The ADVANCE Study
- (2013) G. Lowe et al. DIABETES
- Targeting Interleukin-6 in Rheumatoid Arthritis
- (2013) Md Yuzaiful Md Yusof et al. DRUGS
- Components of the Interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness
- (2013) Thomas W. Weiss et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- IL-6 Regulates Mcl-1L Expression through the JAK/PI3K/Akt/CREB Signaling Pathway in Hepatocytes: Implication of an Anti-Apoptotic Role during Liver Regeneration
- (2013) Chia-Hung Chou et al. PLoS One
- Inflammatory Markers and Risk of Type 2 Diabetes: A systematic review and meta-analysis
- (2012) X. Wang et al. DIABETES CARE
- The role of tocilizumab in the management of rheumatoid arthritis
- (2012) Zoe Ash et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Hitting a complex target: an update on interleukin-6 trans-signalling
- (2012) Georg H Waetzig et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6
- (2012) Stefan Rose-John International Journal of Biological Sciences
- Tocilizumab Treatment Decreases Circulating Myeloid Dendritic Cells and Monocytes, 2 Components of the Myeloid Lineage
- (2012) C. RICHEZ et al. JOURNAL OF RHEUMATOLOGY
- Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies
- (2012) LANCET
- The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis
- (2012) LANCET
- Therapeutic Targeting of the Interleukin-6 Receptor
- (2011) Toshio Tanaka et al. Annual Review of Pharmacology and Toxicology
- Transsignaling of Interleukin-6 Crucially Contributes to Atherosclerosis in Mice
- (2011) Harald Schuett et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- A pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor inhibition in rheumatoid arthritis
- (2011) A.D. Protogerou et al. ATHEROSCLEROSIS
- The pro- and anti-inflammatory properties of the cytokine interleukin-6
- (2011) Jürgen Scheller et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Species Specificity of ADAM10 and ADAM17 Proteins in Interleukin-6 (IL-6) Trans-signaling and Novel Role of ADAM10 in Inducible IL-6 Receptor Shedding
- (2011) Christoph Garbers et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of Classic Signaling Is a Novel Function of Soluble Glycoprotein 130 (sgp130), Which Is Controlled by the Ratio of Interleukin 6 and Soluble Interleukin 6 Receptor
- (2011) Christoph Garbers et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Atherosclerosis: current pathogenesis and therapeutic options
- (2011) Christian Weber et al. NATURE MEDICINE
- Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells
- (2011) Helga Ellingsgaard et al. NATURE MEDICINE
- Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
- (2011) Jeng-Jiann Chiu et al. PHYSIOLOGICAL REVIEWS
- Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance
- (2010) V. B. Matthews et al. DIABETOLOGIA
- Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation
- (2010) Shigeru Kotake et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Contribution of vascular cell-derived cytokines to innate and inflammatory pathways in atherogenesis
- (2010) Harald Loppnow et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Differences in Wound Healing in Mice with Deficiency of IL-6 versus IL-6 Receptor
- (2010) M. M. McFarland-Mancini et al. JOURNAL OF IMMUNOLOGY
- CREB-Mediated IL-6 Expression Is Required for 15(S)-Hydroxyeicosatetraenoic Acid–Induced Vascular Smooth Muscle Cell Migration
- (2009) Koteswara R. Chava et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Changes in Cytokine Levels During Acute Hyperinsulinemia in Offspring of Type 2 Diabetic Subjects
- (2009) Eija Ruotsalainen et al. ATHEROSCLEROSIS
- Interleukin-6 Attenuates Insulin-Mediated Increases in Endothelial Cell Signaling but Augments Skeletal Muscle Insulin Action via Differential Effects on Tumor Necrosis Factor- Expression
- (2009) D. Y.C. Yuen et al. DIABETES
- Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT)
- (2008) Aramesh Saremi et al. ATHEROSCLEROSIS
- Prolonged interleukin-6 administration enhances glucose tolerance and increases skeletal muscle PPARα and UCP2 expression in rats
- (2008) Anna G Holmes et al. JOURNAL OF ENDOCRINOLOGY
- Interleukin-6 regulates pancreatic -cell mass expansion
- (2008) H. Ellingsgaard et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now